[Experimental assessment of the effect of dimephosphone on ulcerogenesis].
Mosina
L M
LM
Vlasov
A P
AP
Plotnikova
N A
NA
Rodina
O P
OP
D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D002374:Catalase / Q000097:blood / Q000378:metabolism; D004195:Disease Models, Animal; D005753:Gastric Mucosa / Q000378:metabolism; D007213:Indomethacin / Q000633:toxicity; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D008054:Lipid Peroxides / Q000097:blood / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009092:Mucous Membrane / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D010741:Phospholipases A / Q000097:blood / Q000378:metabolism; D051381:Rats; D013270:Stomach / Q000187:drug effects / Q000473:pathology
D000975:Antioxidants; D008054:Lipid Peroxides; D009943:Organophosphorus Compounds; C049638:dimephosphon; D002374:Catalase; D010741:Phospholipases A; D007213:Indomethacin